Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
[Plasma theophylline level in patients with bronchial asthma treated with novphyllin].
Kosturkov G, Mileva Zh, Vasileva S, Dimitrov V, Slavov S. Kosturkov G, et al. Vutr Boles. 1982;21(5):104-9. Vutr Boles. 1982. PMID: 7164400 Bulgarian.
The authors followed up the plasma theophylline level in 51 patients with bronchial asthma treated with novphyllin. Plasma theophylline level was determined (according to Jatlow--1975) before novphyllin intake and by 1, 2, 4 and 8 hour after it. The investigation wa …
The authors followed up the plasma theophylline level in 51 patients with bronchial asthma treated with novphyllin. Plasma theophylli …
Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy.
Petrova G, Stoimenova A, Dimitrova M, Kamusheva M, Petrova D, Georgiev O. Petrova G, et al. SAGE Open Med. 2017 Jan 31;5:2050312117690404. doi: 10.1177/2050312117690404. eCollection 2017. SAGE Open Med. 2017. PMID: 28228952 Free PMC article.
The relative risk of developing an adverse drug reaction was highest for novphyllin (relative risk = 0.65), followed by aclidinium bromide (relative risk = 0.09). ...
The relative risk of developing an adverse drug reaction was highest for novphyllin (relative risk = 0.65), followed by aclidinium br …